Martin Erixon joins Hamlet Pharma as new CEO
Hamlet Pharma enters a new business development phase involving multiple cancer indications and markets. Based on the successful outcomes of our clinical trial program, we are progressing towards Phase III trials and are expanding our product portfolio.Martin Erixon has extensive experience from the Medical/Pharmaceutical industry as well as from the Food Processing industry. Based on a Ph.D. in Chemistry from the University of Lund and a Master of Science, Martin Erixon has developed a successful career in large corporations such as Gambro (Baxter) and Tetra Pak, one of the largest food